Golf News

PGA Tour Partners with Zyrtec as Official Allergy Relief Sponsor

July 11, 2026Carlos Mendoza2 мин

The PGA Tour has officially partnered with Zyrtec, designating the allergy relief brand as its first-ever Official Allergy Relief Sponsor. This multi-year agreement aims to provide essential relief to both professional golfers and fans grappling with seasonal allergies, which are particularly prevalent during the spring golf season when pollen counts are often at their peak.

Golf courses, with their extensive exposure to grass and various types of pollen, frequently exacerbate allergy symptoms. These symptoms can impact player performance and diminish the enjoyment for spectators. Reports indicate that a significant majority—up to 85%—of PGA Tour players are affected by allergies, highlighting the relevance of Zyrtec as a trusted allergy solution in this environment.

Professional golfer Akshay Bhatia, a three-time PGA Tour winner, and rising star Neal Shipley have both been named player ambassadors for Zyrtec. Bhatia shared his personal experience, noting that his intense allergy symptoms often coincide with the most crucial tournaments of his career. "I've relied on Zyrtec for years as part of my routine," Bhatia explained, "to ensure that even at events with high allergen counts, my performance on the course remains unaffected." This sentiment underscores the authenticity of the partnership, as both ambassadors were already users of Zyrtec due to their personal struggles with allergies.

Kenvue, Zyrtec's parent company, launched its "Yes Season" campaign in conjunction with this partnership. The initiative is rooted in the understanding that seasonal allergies frequently lead individuals to cancel or avoid activities they love. By providing effective allergy relief, Zyrtec empowers people to say "yes" to outdoor experiences like golf, even during peak allergy season.

Beyond player endorsements, Zyrtec has actively engaged with fans at various Tour events, including those in Florida. On-site activations such as the "Pollen PuttPutt" and "The Relief Club" offered interactive experiences, free product samples, branded golf towels, and refreshments. These initiatives not only educated fans about allergy relief but also provided tangible comfort, making their tournament experience more enjoyable.

Jenn Lovell, Commercial Head of US Allergy at Kenvue, emphasized the strategic alignment of the partnership: "Golf demands extreme precision, and the slightest distraction—whether an itchy eye during a critical putt or a sneeze mid-swing—can significantly hinder performance. It's not just about comfort; it's a competitive necessity."

The partnership extends to future tournaments, with Zyrtec planning to maintain its presence at additional events in 2026, including the RBC Heritage in April, the Truist Championship in May, and the Tour Championship later in the summer.

Dan Glod, Executive Vice President of Corporate Partnerships for the PGA Tour, expressed enthusiasm for the collaboration: "We are delighted to welcome Zyrtec into our marketing family as the Official Allergy Relief Sponsor. Providing on-site relief for our players and fans is particularly exciting as the golf season moves into spring and allergy season intensifies."